Open AccessP063: Trial in Progress: Individualized Immunotherapy in Early‐Stage Unfavorable Hodgkin Lymphoma ‐ The Investigator‐Initiated Phase II GHSG INDIE Trial
Author(s) -
Bröckelmann Paul J.,
Kaul Helen,
Fuchs Michael,
Kobe Carsten,
Baues Christian,
Borchmann Peter,
Engert Andreas
Publication year - 2022
Publication title -
hemasphere
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000890820.12468.10
Subject(s) - medicine , nivolumab , dacarbazine , oncology , concomitant , progression free survival , immunotherapy , chemotherapy , cancer